BRPI1008227A2 - composição de glicocorticoide inalavel para uso na terapia de um paciente que sofre de asma severa e sem controle. - Google Patents
composição de glicocorticoide inalavel para uso na terapia de um paciente que sofre de asma severa e sem controle.Info
- Publication number
- BRPI1008227A2 BRPI1008227A2 BRPI1008227A BRPI1008227A BRPI1008227A2 BR PI1008227 A2 BRPI1008227 A2 BR PI1008227A2 BR PI1008227 A BRPI1008227 A BR PI1008227A BR PI1008227 A BRPI1008227 A BR PI1008227A BR PI1008227 A2 BRPI1008227 A2 BR PI1008227A2
- Authority
- BR
- Brazil
- Prior art keywords
- severe
- therapy
- patient suffering
- uncontrolled asthma
- glucocorticoid composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/365,754 US20100196483A1 (en) | 2009-02-04 | 2009-02-04 | Method for treatmentof severe and uncontrollable asthma |
PCT/EP2010/051321 WO2010089330A1 (en) | 2009-02-04 | 2010-02-03 | Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI1008227A2 true BRPI1008227A2 (pt) | 2016-03-08 |
BRPI1008227A8 BRPI1008227A8 (pt) | 2018-12-11 |
Family
ID=42153807
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI1008227A BRPI1008227A8 (pt) | 2009-02-04 | 2010-02-03 | composição de glicocorticoide inalável para uso na terapia de um paciente que sofre de asma severa e sem controle. |
Country Status (22)
Country | Link |
---|---|
US (1) | US20100196483A1 (pt) |
EP (2) | EP3338782A1 (pt) |
JP (1) | JP5886630B2 (pt) |
KR (1) | KR20110122671A (pt) |
CN (2) | CN102307567A (pt) |
AU (1) | AU2010210183B2 (pt) |
BR (1) | BRPI1008227A8 (pt) |
CA (1) | CA2751443C (pt) |
DK (1) | DK2393477T3 (pt) |
ES (1) | ES2659328T3 (pt) |
HU (1) | HUE038553T2 (pt) |
IL (1) | IL213959A (pt) |
MX (1) | MX2011008200A (pt) |
NO (1) | NO2393477T3 (pt) |
NZ (1) | NZ594210A (pt) |
PL (1) | PL2393477T3 (pt) |
PT (1) | PT2393477T (pt) |
RU (1) | RU2519344C2 (pt) |
SG (1) | SG173538A1 (pt) |
SI (1) | SI2393477T1 (pt) |
UA (1) | UA102587C2 (pt) |
WO (1) | WO2010089330A1 (pt) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009079078A1 (en) | 2007-12-14 | 2009-06-25 | Labogroup S.A.S. | Delivering aerosolizable food products |
NZ628562A (en) | 2012-03-09 | 2015-08-28 | Vectura Gmbh | Mixing channel for an inhalation device and inhalation device |
WO2014012954A1 (en) * | 2012-07-18 | 2014-01-23 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma |
US20140261474A1 (en) * | 2013-03-15 | 2014-09-18 | Aradigm Corporation | Methods for inhalation of smoke-free nicotine |
US8807131B1 (en) | 2013-06-18 | 2014-08-19 | Isonea Limited | Compliance monitoring for asthma inhalers |
EP3054948B1 (en) | 2013-10-08 | 2020-08-12 | AI Therapeutics, Inc. | Rapamycin for the treatment of lymphangioleiomyomatosis |
CA2936332A1 (en) * | 2014-01-22 | 2015-07-30 | Takeda Gmbh | Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier) |
BR112016022598A8 (pt) * | 2014-04-04 | 2021-06-29 | Ai Therapeutics Inc | composição aerossol farmacêutica na forma de um pó seco para liberação pulmonar, forma de dosagem unitária, pacote farmacêutico, kit e uso |
WO2015197798A1 (en) * | 2014-06-25 | 2015-12-30 | Optinose As | Nasal administration |
EP3209330B1 (en) | 2014-10-07 | 2022-02-23 | AI Therapeutics, Inc. | An inhalable sirolimus formulation for the treatment of pulmonary hypertension |
RU2611406C1 (ru) * | 2015-09-03 | 2017-02-21 | Общество с ограниченной ответственностью "Биосурф" (ООО "Биосурф") | Способ лечения бронхиальной астмы |
ES2894895T3 (es) | 2016-07-08 | 2022-02-16 | Trudell Medical Int | Dispositivo de presión espiratoria positiva oscilante inteligente |
ES2920151T3 (es) | 2016-12-09 | 2022-08-01 | Trudell Medical Int | Nebulizador inteligente |
MX2020007026A (es) | 2018-01-04 | 2020-12-03 | Trudell Medical Int | Dispositivo de presión espiratoria positiva oscilante inteligente. |
EP4021542A4 (en) | 2019-08-27 | 2023-09-06 | Trudell Medical International | INTELLIGENT OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICE |
US11593679B2 (en) * | 2019-11-29 | 2023-02-28 | Kpn Innovations, Llc. | Method of and system for generating a longevity element and an instruction set for a longevity element plan |
WO2022164616A1 (en) * | 2021-01-29 | 2022-08-04 | AsthmaTek, Inc. | Systems and methods to determine a therapy regimen to treat asthma of a subject |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19720701A1 (de) * | 1997-05-16 | 1998-11-19 | Gsf Forschungszentrum Umwelt | Vorrichtung zur Applikation eines Medikament-Aerosols über die Lunge |
US6187765B1 (en) * | 1997-10-09 | 2001-02-13 | Schering Corporation | Mometasone furoate suspensions for nebulization |
DE19851279B4 (de) * | 1998-06-17 | 2006-05-24 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zum gesteuerten inhalatorischen Einbringen von dosierten Medikamenten in die Lunge |
DE19912265A1 (de) * | 1999-03-18 | 2000-09-21 | Gsf Forschungszentrum Umwelt | Verfahren und Vorrichtung zur Bereitstellung einer konstanten Medikamenten-Dosis für eine inhalatorische Applikation mit niedrigem Inhalationsfluß |
DE19912461B4 (de) * | 1999-03-19 | 2006-07-20 | GSF - Forschungszentrum für Umwelt und Gesundheit GmbH | Vorrichtung zur Flußbegrenzung bei niedrigen Differenzdrücken |
DE10013093B4 (de) * | 2000-03-17 | 2005-12-22 | Inamed Gmbh | Vorrichtung zur kontrollierten Inhalation therapeutischer Aerosole |
DE10029119B4 (de) * | 2000-06-14 | 2005-12-22 | Institut für Aerosol Medizin InAMed GmbH | Inhalationsvorrichtung |
DE10123749A1 (de) * | 2001-05-16 | 2002-12-12 | Inamed Gmbh | Vorrichtung zum Verabreichen von Aerosolen |
CN1976679B (zh) * | 2003-12-31 | 2011-08-31 | 锡德克斯药物公司 | 含有磺基烷基醚环糊精以及皮质甾类的吸入制剂 |
US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
ES2414869T3 (es) * | 2005-03-08 | 2013-07-23 | Activaero Gmbh | Dispositivo de inhalación |
DE502005001542D1 (de) * | 2005-07-06 | 2007-10-31 | Activaero Gmbh | Regelbares Ventil und Inhalationsvorrichtung |
KR100802292B1 (ko) * | 2006-07-21 | 2008-02-11 | 동부일렉트로닉스 주식회사 | 마스크 및 이를 이용한 마이크로 렌즈 제작 방법 |
CN101795565A (zh) * | 2007-06-28 | 2010-08-04 | 锡德克斯药物公司 | 皮质类固醇水溶液的鼻部和眼部给药 |
CN102186458A (zh) * | 2008-10-14 | 2011-09-14 | 艾克蒂维罗有限责任公司 | 治疗慢性阻塞性肺病及其它肺疾病的方法 |
-
2009
- 2009-02-04 US US12/365,754 patent/US20100196483A1/en not_active Abandoned
-
2010
- 2010-02-03 PT PT107059867T patent/PT2393477T/pt unknown
- 2010-02-03 CN CN201080006616XA patent/CN102307567A/zh active Pending
- 2010-02-03 EP EP17206605.2A patent/EP3338782A1/en active Pending
- 2010-02-03 EP EP10705986.7A patent/EP2393477B1/en not_active Revoked
- 2010-02-03 CA CA2751443A patent/CA2751443C/en active Active
- 2010-02-03 ES ES10705986.7T patent/ES2659328T3/es active Active
- 2010-02-03 PL PL10705986T patent/PL2393477T3/pl unknown
- 2010-02-03 JP JP2011548677A patent/JP5886630B2/ja active Active
- 2010-02-03 RU RU2011135824/15A patent/RU2519344C2/ru active
- 2010-02-03 AU AU2010210183A patent/AU2010210183B2/en active Active
- 2010-02-03 NZ NZ594210A patent/NZ594210A/xx unknown
- 2010-02-03 UA UAA201110621A patent/UA102587C2/ru unknown
- 2010-02-03 HU HUE10705986A patent/HUE038553T2/hu unknown
- 2010-02-03 DK DK10705986.7T patent/DK2393477T3/en active
- 2010-02-03 CN CN201410371150.3A patent/CN104306360A/zh active Pending
- 2010-02-03 BR BRPI1008227A patent/BRPI1008227A8/pt not_active Application Discontinuation
- 2010-02-03 WO PCT/EP2010/051321 patent/WO2010089330A1/en active Application Filing
- 2010-02-03 KR KR1020117017903A patent/KR20110122671A/ko active Search and Examination
- 2010-02-03 SI SI201031650T patent/SI2393477T1/en unknown
- 2010-02-03 MX MX2011008200A patent/MX2011008200A/es active IP Right Grant
- 2010-02-03 NO NO10705986A patent/NO2393477T3/no unknown
- 2010-02-03 SG SG2011056207A patent/SG173538A1/en unknown
-
2011
- 2011-07-06 IL IL213959A patent/IL213959A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
UA102587C2 (ru) | 2013-07-25 |
EP3338782A1 (en) | 2018-06-27 |
CN102307567A (zh) | 2012-01-04 |
HUE038553T2 (hu) | 2018-10-29 |
IL213959A (en) | 2015-05-31 |
NO2393477T3 (pt) | 2018-05-26 |
SI2393477T1 (en) | 2018-04-30 |
JP5886630B2 (ja) | 2016-03-16 |
WO2010089330A1 (en) | 2010-08-12 |
CA2751443A1 (en) | 2010-08-12 |
AU2010210183A1 (en) | 2011-07-28 |
IL213959A0 (en) | 2011-08-31 |
JP2012516873A (ja) | 2012-07-26 |
BRPI1008227A8 (pt) | 2018-12-11 |
AU2010210183B2 (en) | 2014-09-11 |
EP2393477A1 (en) | 2011-12-14 |
NZ594210A (en) | 2013-09-27 |
US20100196483A1 (en) | 2010-08-05 |
RU2519344C2 (ru) | 2014-06-10 |
KR20110122671A (ko) | 2011-11-10 |
PL2393477T3 (pl) | 2018-06-29 |
SG173538A1 (en) | 2011-09-29 |
CN104306360A (zh) | 2015-01-28 |
DK2393477T3 (en) | 2018-04-09 |
PT2393477T (pt) | 2018-02-14 |
CA2751443C (en) | 2018-03-20 |
EP2393477B1 (en) | 2017-12-27 |
RU2011135824A (ru) | 2013-03-10 |
ES2659328T3 (es) | 2018-03-14 |
MX2011008200A (es) | 2011-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI1008227A2 (pt) | composição de glicocorticoide inalavel para uso na terapia de um paciente que sofre de asma severa e sem controle. | |
HK1202558A1 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
CL2007002791A1 (es) | Compuestos derivados de sulfonamida; composicion farmaceutica que comprende a estos compuestos; combinacion farmaceutica que comprende a estos compuestos; y su uso para tratar trastornos, enfermedades y afecciones seleccionadas de asma, broncoconstri | |
IL236892B (en) | A combination of an immunoconjugate and an antibody for use in medical treatment, a pharmaceutical preparation and a kit containing it | |
UY31686A1 (es) | Nueva dosificacion y formulacion | |
CL2012003290A1 (es) | Metodo para preparar una composicion enriquecida en igg a partir de plasma; composicion acuosa de igg; composicion farmaceutica que comprende dicha composicion acuosa; uso de dicha composicion para tratar enfermedad autoinmune o infeccion aguda | |
EP2259782A4 (en) | PHARMACEUTICAL FORMULATIONS OF RESVERATROL AND METHOD FOR THEIR USE IN THE TREATMENT OF CELL DISEASES | |
BR112012008854A2 (pt) | combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano | |
CL2007002121A1 (es) | Compuestos derivados de pirazoles, activadores de glucoquinasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que comprende dichos compuestos; y uso para el tratamiento de enfermedades y/o trastornos metabolicos, tal como diab | |
EP2437743A4 (en) | OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE | |
BRPI1013288A2 (pt) | uso de um composto, método de composição farmacêutica para o tratamento de doenças em que a motilidade gastrointestinal anormal está envolvida, kit e embalagem comercial que compreende uma composição farmacêutica contendo o composto | |
BRPI0908503A2 (pt) | partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos | |
GT201400182A (es) | Formulaciones farmacéuticas novedosas | |
EP2300028A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING EFFICIENT HUANGLIAN (COPTIS SINENSIS) AND KU DING CHA EXTRACTS AS HYPOLIPEMANTS | |
UY31687A1 (es) | Nueva dosificacion y formulacion | |
BRPI1009781A2 (pt) | compostos para o tratamento de distúrbios metabólicos, composição farmacêutica que os compreende e uso dos mesmos | |
ZA201403431B (en) | Pharmaceutical compositions and methods of use of 4-pregenen-11b-21-triol-3,20-dione derivatives | |
EP2464383A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF FLU | |
EP2370068A4 (en) | METHOD AND COMPOSITIONS FOR DELIVERING MEDICAMENTS TO THE LUNG | |
IL218656A (en) | Preparations containing pancreatic enzyme and use in the preparation of a drug for the treatment of pancreatitis and pancreatic failure | |
EP2049662A4 (en) | METHODS AND COMPOSITIONS FOR INCREASING REPLICATION CAPACITY OF A FLU VIRUS | |
HK1197235A1 (zh) | 二氫吡唑、其藥物組合物及其治療生育障礙的用途 | |
CL2008000047A1 (es) | Compuestos derivados de sulfonamida; procedimiento de preparacion; composicion farmaceutica que contiene a dichos compuestos; y su uso en el tratamiento y profilaxis de aterotrombosis y asma. | |
EP2377934A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUMOR AND ASTHMA | |
BRPI1008276A2 (pt) | processo para a preparação e uso de uma composição |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: ACTIVAERO GMBH (DE) |
|
B25G | Requested change of headquarter approved |
Owner name: ACTIVAERO GMBH (DE) |
|
B25D | Requested change of name of applicant approved |
Owner name: VECTURA GMBH (DE) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |